Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.24.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and Cash Equivalents $ 5,637,019 $ 2,454,684
Short-Term Investments 23,398,016 0
Prepaid Expenses and Other Current Assets 470,424 233,382
Collaboration Receivables 1,783,472 0
Tax and Other Receivables 363,706 2,049,965
Total Current Assets 31,652,637 4,738,031
Non-Current Assets:    
Property and Equipment, Net 62,609 8,065
Restricted Cash 4,520 4,267
Intangible Assets and In-Process R&D, Net 6,687,100 8,813,850
Operating Lease Assets with Right-of-Use 72,637 106,890
Other Assets 29,851 40,767
Total Assets 38,509,354 13,711,870
Current Liabilities:    
Accounts Payable 660,415 206,260
Accrued Expenses 1,714,211 1,380,666
Accrued Collaboration Credit 1,119,591 0
Operating Lease Liabilities 33,447 47,069
Total Current Liabilities 3,527,664 1,633,995
Non-Current Liabilities:    
Contingent Consideration 4,133,008 5,128,959
Deferred Tax Liability 779,440 779,440
Operating Lease Liabilities 39,190 59,822
Total Non-Current Liabilities 4,951,638 5,968,221
Total Liabilities 8,479,302 7,602,216
Commitments and Contingencies (Note 8)
Stockholders’ Equity:    
Preferred Stock 4 4
Common Stock, $0.01 Par Value: 150,000,000 and 50,000,000 shares authorized; 3,000,788 and 856,182 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 267,679 77,078
Additional Paid-In Capital 168,996,195 153,192,228
Accumulated Deficit (139,158,620) (146,976,855)
Accumulated Other Comprehensive Loss (75,206) (182,801)
Total Stockholders’ Equity 30,030,052 6,109,654
Total Liabilities and Stockholders’ Equity $ 38,509,354 $ 13,711,870